249 related articles for article (PubMed ID: 8980384)
1. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
Withoff S; de Vries EG; Keith WN; Nienhuis EF; van der Graaf WT; Uges DR; Mulder NH
Br J Cancer; 1996 Dec; 74(12):1869-76. PubMed ID: 8980384
[TBL] [Abstract][Full Text] [Related]
2. Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells.
Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
Jpn J Cancer Res; 2001 Jul; 92(7):778-84. PubMed ID: 11473729
[TBL] [Abstract][Full Text] [Related]
3. Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel.
Withoff S; Keith WN; Knol AJ; Coutts JC; Hoare SF; Mulder NH; de Vries EG
Br J Cancer; 1996 Aug; 74(4):502-7. PubMed ID: 8761362
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
5. Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance.
Versantvoort CH; Withoff S; Broxterman HJ; Kuiper CM; Scheper RJ; Mulder NH; de Vries EG
Int J Cancer; 1995 May; 61(3):375-80. PubMed ID: 7729950
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.
Kreisholt J; Sorensen M; Jensen PB; Nielsen BS; Andersen CB; Sehested M
Br J Cancer; 1998 May; 77(9):1469-73. PubMed ID: 9652763
[TBL] [Abstract][Full Text] [Related]
8. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
de Jong S; Zijlstra JG; de Vries EG; Mulder NH
Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
[TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
10. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
11. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
Matsumoto Y; Takano H; Nagao S; Fojo T
Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765
[TBL] [Abstract][Full Text] [Related]
12. Decreased levels of topoisomerase II alpha in human renal cell carcinoma lines resistant to etoposide.
Scheltema JM; Romijn JC; van Steenbrugge GJ; Beck WT; Schröder FH; Mickisch GH
J Cancer Res Clin Oncol; 1997; 123(10):546-54. PubMed ID: 9393588
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon.
Eijdems EW; De Haas M; Coco-Martin JM; Ottenheim CP; Zaman GJ; Dauwerse HG; Breuning MH; Twentyman PR; Borst P; Baas F
Int J Cancer; 1995 Mar; 60(5):676-84. PubMed ID: 7860142
[TBL] [Abstract][Full Text] [Related]
14. CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
Jansen WJ; Hulscher TM; van Ark-Otte J; Giaccone G; Pinedo HM; Boven E
Br J Cancer; 1998; 77(3):359-65. PubMed ID: 9472629
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation.
Boonstra R; Timmer-Bosscha H; van Echten-Arends J; van der Kolk DM; van den Berg A; de Jong B; Tew KD; Poppema S; de Vries EG
Br J Cancer; 2004 Jun; 90(12):2411-7. PubMed ID: 15150577
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6.
Ishii M; Iwahana M; Mitsui I; Minami M; Imagawa S; Tohgo A; Ejima A
Anticancer Drugs; 2000 Jun; 11(5):353-62. PubMed ID: 10912951
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.
Hendrikse NH; Franssen EJ; van der Graaf WT; Meijer C; Piers DA; Vaalburg W; de Vries EG
Br J Cancer; 1998; 77(3):353-8. PubMed ID: 9472628
[TBL] [Abstract][Full Text] [Related]
18. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone.
Nielsen D; Eriksen J; Maare C; Litman T; Kjaersgaard E; Plesner T; Friche E; Skovsgaard T
Biochem Pharmacol; 2000 Aug; 60(3):363-70. PubMed ID: 10856431
[TBL] [Abstract][Full Text] [Related]
20. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
